Body composition assessment in Leiria’s 7th graders – a 5 year comparison (2009-2013).

The assessment of body composition in children has taken on greater significance because of the need to study the prevalence of obesity in children and youth and changes over time in a given population

Pathways to interleukin-6 in healthy males and serious leisure male athletes: physical activity, body composition and age.

Physical activity (PA) is beneficial to overall health, in part due to physiological changes that lower risk factors for cardiovascular disease, including reduced inflammation. However, the mechanism by which PA reduces inflammation is unclear. One possible pathway is that PA improves body composition which in turn reduces inflammation. To test this hypothesis, we used structural equation modeling (SEM) to assess PA-body composition -inflammation pathways, as well as influences of age. In a sample of 72 healthy males with a range of PA profiles (age 18-65, mean ± sd = ), we measured PA as metabolic equivalent tasks (as per the International PA Questionnaire), body composition as percent body fat, lean mass, and fat mass, and inflammation as plasma interleukin-6 (IL-6). We treated body composition in the SEM analysis as a latent variable indicated by the three measures. We performed statistical corrections for missing values and one outlier. The model demonstrated significant effects of PA on IL-6 both directly and through body composition. Percent body fat, fat mass, and lean mass were significant indicators of the body composition latent variable. Additionally, age showed an indirect effect on IL-6 through body composition, but no direct effect. The findings suggest that PA does improve inflammatory profile through improving body composition, but that other pathways also exist

Body composition estimated by bioelectrical impedance analyses is diminished by prenatal stress in neonatal lambs and by heat stress in feedlot wethers

Body composition correlates to carcass value in livestock, which makes the ability to accurately estimate body composition in the live animal beneficial (Berg and Marchello, 1994). Bioelectrical impedance analysis (BIA) is a clinical tool used to assess body composition in humans (Lukaski et al., 1985), but its use in livestock has been minimal. Lean and fat content contribute to profitability for livestock producers, and poor body composition can be caused by stress that occurs either during in utero development (De Blasio et al., 2007) or during postnatal growth (Boyd et al., 2015). Maternal hyperthermia-induced placental insufficiency (Brown et al., 2015) and sustained maternal inflammation (Cadaret et al., 2018) are two established causes of intrauterine growth restriction (IUGR). IUGR-born animals are characterized by asymmetrical growth restriction that alters lifelong body composition due to impaired muscle growth capacity (Yates et al., 2018). In addition, acute heat stress during periods of peak postnatal growth can alter body composition in livestock (Boyd et al., 2015). We postulate that BIA can detect these changes in the live animal. Thus, the objective of this study was to determine whether BIA measurements can predict changes to body composition in live neonatal lambs exposed to intrauterine stress and in heat-stressed feedlot lambs

Comparison of Bioelectrical Impedance Analysis Instruments and Skinfold Calipers in the Determination of Percent Body Fat in Division I Tennis Players

Body composition, specifically percent body fat, is an important measurement performed in both the clinical and educational settings. Very reliable and accurate systems for measuring body composition are available for use, but they are time-consuming and very expensive, such as dual x-ray absorptiometry and hydrostatic weighing. Attempting to find technology that is inexpensive and easy to operate in determining body composition is a difficult task. However, bioelectrical impedance analysis machines offer the possibility of fulfilling this need in the educational and clinical settings. The question that needs to be answered is whether the bioelectrical impedance analyzers are a reliable and accurate tool in determining body composition in the clinical or educational setting. In this research, there will be three different trial sessions. Each session will consist of four different body composition tests. The results of these tests will be analyzed using Pearson’s r correlation to show statistical significance between trials and instruments

Sex-Mediated Differences Among University Students Performing Extreme Physical Activity During The 3-Minute Burpee Test

Introduction. The aim of this study was to evaluate sex differences in anthropometric indicators, body composition, physical fitness, and physiological parameters in young women and men performing extremely strenuous exercise during the 3-Minute Burpee Test (3-MBT). Post-exercise recovery during a 6-minute break was determined in the tested subjects. Material and methods. Ninety-six university students volunteered to take part in this study (45 women aged 20.05 ± 1.81 years and 51 men aged 20.20 ± 2.71 years). Endurance-strength abilities were determined during the 3-MBT motor fitness test, and body composition was determined with an InBody720 analyser. Data were analysed using a Mann-Whitney U test, with statistical significance accepted at p ≤ 0.05. Results. The anthropometric indicators, body composition parameters, physical fitness levels (47.22 cycles/3 min), and physiological parameters measured during the 3-MBT were significantly higher in men (VO2avg – 41.57 mL/kg/min, VO2max – 49.67 mL/kg/min, EPOCavg – 11.02mL/kg, and EPOCpeak – 27.84mL/kg) than in women. Women were characterised by significantly higher (p < 0.05) body fat mass (BFM = 18.80 kg) and percent body fat (PBF 28.26%) than men. Conclusions. Male subjects were characterised by higher values of anthropometric indicators, body composition parameters (excluding body fat), motor fitness levels, and physiological parameters than women, and endurance-strength abilities were 23.75% higher, on average, in men than women

A pilot study of temsirolimus and body composition.

PurposeBody weight and composition play a role in cancer etiology, prognosis, and treatment response. Therefore, we analyzed the weight, body composition changes, and outcome in patients treated with temsirolimus, an mTor inhibitor that has weight loss as one of its side effects.Patients and methodsSixteen patients with advanced solid tumors treated with temsirolimus were studied; body composition was evaluated utilizing computerized tomography images. Sarcopenia was defined as skeletal muscle index lower than 38.5 cm(2)/m(2) for women and 52.4 cm(2)/m(2) for men.ResultsFive of 16 patients (31 %) were men; median age, 60 years. Forty-four percent (7/16) of patients were sarcopenic. Fatigue, anemia, hyperglycemia, and hyperlipidemia were common. Baseline sarcopenia and body composition did not correlate with worse toxicity or treatment outcome. However, there was a trend for greater loss of adipose area (p = 0.07), fat mass (p = 0.09), and adipose index (p = 0.07) for patients with grade 3 or 4 toxicities versus those with grade 1 and 2 side effects.ConclusionPatients with higher grade toxicities tended to lose more body fat, suggesting a possible end-organ metabolic effect of temsirolimus. These observations merit exploration in a larger cohort of patients

The Change of Body Composition of Indigenous Rams on Different Body Weight and Feeding Level

The aim of this research was to investigate the influence of body weight and feeding level on the changeof body composition of indigenous ram. This research was expected to establish the efficient feeding levelto produce high growth rate and meat quality of ram in tropical environment. Sixteen rams with differentbody weight (BW) were divided into 2 groups, i.e. light BW (10 + 1.47 kg) and heavy BW (18 + 1.18 kg).The experimental design was Split Plot design with two factors. The main plot was body weight (light andheavy) and the sub plot was level of feeding (FL, 1x maintenance and 1.5 x maintenance). The parametersmeasured in this experiment were live weight gain and body composition. The results of this study showedthat body water, body protein and body fat were significantly higher (P<0.01) in heavy body weight (HBW)than those in light body weight (LBW), and was higher in 1.5xM than those 1xM. Ram of HW and LW hadsimilar change rate of physical composition. Ram given 1.5xM had higher rate of change of body fat andbody water than those given feed at maintenance level. It can be concluded that there was no interactionbetween BW and FL on the change of body water, body protein and body fat. Ram of HBW and LBW hadsimilar rate of change of physical composition. Level of feeding affected body water content, the higherlevel of feeding resulted in fatter ram, leading to less body water content

The Extra Load Index as a method for comparing the relative economy of load carriage systems

The Extra Load Index (ELI) has been proposed as a suitable method of assessing the relative economy of load carriage systems. The purpose of this study was to determine, based on empirical evidence, that the ELI can accommodate variations in both body composition and added load. In total, 30 women walked carrying loads of up to 70% body mass at self-selected walking speeds whilst expired air was collected. In addition, each of the women had body composition assessed via dual energy X-ray absorptiometry. Results show that the ELI is independent of body composition variables, the magnitude of additional loads and the speed of progression. Consequently, it is suggested that it represents an appropriate method of comparing load carriage systems in both scientific and commercial arenas. Statement of Relevance:This paper demonstrates that ELI is independent of body composition, added load and speed and is therefore an appropriate method to generalise comparisons of load carriage systems. It has the advantage of being easily understood by manufacturers and consumers whilst retaining appropriate scientific precision

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes:a substudy of the SUSTAIN 8 randomised, controlled clinical trial

Aims/hypothesis: Intra-abdominal or visceral obesity is associated with insulin resistance and an increased risk for cardiovascular disease. This study aimed to compare the effects of semaglutide 1.0 mg and canagliflozin 300 mg on body composition in a subset of participants from the SUSTAIN 8 Phase IIIB, randomised double-blind trial who underwent whole-body dual-energy x-ray absorptiometry (DXA) scanning.Methods: Adults (age ≥18 years) with type 2 diabetes, HbA 1c 53–91 mmol/mol (7.0–10.5%), on a stable daily dose of metformin (≥1500 mg or maximum tolerated dose) and with an eGFR ≥60 ml min −1 [1.73 m] −2 were randomised 1:1 to semaglutide 1.0 mg once weekly and canagliflozin placebo once daily, or canagliflozin 300 mg once daily and semaglutide placebo once weekly. Body composition was assessed using whole-body DXA scans. The study participants and investigator remained blinded throughout the trial, and quality of DXA scans was evaluated in a blinded manner. Change from baseline to week 52 in total fat mass (kg) was the confirmatory efficacy endpoint.Results: A subset of 178 participants (semaglutide, n = 88; canagliflozin, n = 90) underwent DXA scanning at screening and were randomised into the substudy. Of these, 114 (semaglutide, n = 53; canagliflozin, n = 61) participants had observed end-of-treatment data included in the confirmatory efficacy analysis. Of the 178 participants in the substudy, numerical improvements in body composition (including fat mass, lean mass and visceral fat mass) were observed after 52 weeks with both treatments. Total fat mass (baseline 33.2 kg) was reduced by 3.4 kg and 2.6 kg with semaglutide and canagliflozin, respectively (estimated treatment difference: –0.79 [95% CI −2.10, 0.51]). Although total lean mass (baseline 51.3 kg) was also reduced by 2.3 kg and 1.5 kg with semaglutide and canagliflozin, respectively (estimated treatment difference: −0.78 [−1.61, 0.04]), the proportion of lean mass (baseline 59.4%) increased by 1.2%- and 1.1%-point, respectively (estimated treatment difference 0.14 [−0.89, 1.17]). Changes in visceral fat mass and overall changes in body composition (assessed by the fat to lean mass ratio) were comparable between the two treatment groups.Conclusions/interpretation: In individuals with uncontrolled type 2 diabetes on stable-dose metformin therapy, the changes in body composition with semaglutide and canagliflozin were not significantly different. Although numerical improvements in body composition were observed following treatment in both treatment arms, the specific impact of both treatments on body composition in the absence of a placebo arm is speculative at this stage. Trial registration: ClinicalTrials.gov NCT03136484. Funding: This trial was supported by Novo Nordisk A/S, Denmark. </p